Navkirat Kahlon
Overview
Explore the profile of Navkirat Kahlon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kahlon N, Kaur J, Doddi S, Burmeister C, Sheikh T, Abuhelwa Z, et al.
Cureus
. 2022 Dec;
14(11):e31206.
PMID: 36505139
Background Coronavirus disease 2019 (COVID-19) infection can vary from asymptomatic infection to multi-organ dysfunction. The most serious complication of infection with COVID-19 is death. Various comorbid conditions and inflammatory markers...
2.
Kahlon N, Doddi S, Yousif R, Najib S, Sheikh T, Abuhelwa Z, et al.
JAMA Netw Open
. 2022 Dec;
5(12):e2245269.
PMID: 36472871
Importance: Melanoma accounts for most of the deaths due to skin cancer. In the past decade, effective US Food and Drug Administration (FDA)-approved therapies for melanoma have emerged. Objective: To...
3.
Verghese C, Li W, Gvazava N, Alimpertis E, Kahlon N, Sun H, et al.
Clin Pathol
. 2022 Oct;
15:2632010X221129242.
PMID: 36313587
Splenic lymphoma may be primary or secondary. Primary splenic lymphoma's are rare and usually of follicular cell origin representing <1% of Non-Hodgkin's Lymphoma's. Most are secondary with 35% representing Marginal...
4.
Kahlon N, Doddi S, Abuhelwa Z, Stanoszek L, Hamouda D
Cureus
. 2022 Oct;
14(9):e29508.
PMID: 36299948
Leukocytosis is defined by an increased WBC count in the peripheral blood. This can be caused by many pathologies from benign conditions such as stress, infection, and inflammation or malignant...
5.
Kahlon N, Shazadeh Safavi P, Abuhelwa Z, Sheikh T, Burmeister C, Doddi S, et al.
Cureus
. 2022 Sep;
14(8):e27862.
PMID: 36110457
Background: Coronavirus disease 2019 (COVID-19) infection is associated with an increased risk of arterial thromboembolic events (ATE) and venous thromboembolic events (VTE). Hypercoagulability associated with COVID-19 infection is multifactorial, and...
6.
Kahlon N, Doddi S, Ning Y, Akpunonu B, Murphy J
Cureus
. 2022 Jul;
14(6):e25907.
PMID: 35844332
Apixaban is known to prolong international normalized ratio (INR) per some observational and in vitro studies. In patients with elevated INR secondary to apixaban use, median INR of 1.4-1.7 has...
7.
Abuhelwa Z, Beran A, Kahlon N, Sayeh W, Khokher W, Assaly R, et al.
Am J Ther
. 2022 Apr;
30(6):e573-e575.
PMID: 35446286
No abstract available.
8.
Ten Eyck J, Kahlon N, Masih S, Hamouda D, Petros F
Cancer Manag Res
. 2022 Mar;
14:729-738.
PMID: 35237074
Background: First-line therapy for treatment of advanced urothelial carcinoma includes combination platinum-based chemotherapies, though resistance and long-term toxicity concerns to these regimens cause limitations in progression-free survival and overall survival....
9.
Abuhelwa Z, Ning Y, Abdulsattar W, Ghazaleh S, Kahlon N, Elsayed A
Am J Ther
. 2021 Nov;
28(6):e685-e687.
PMID: 34757966
No abstract available.